Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial. ReNeu: A pivotal phase 2b trial of mirdametinib in children and adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback